Jenkins [49] found that RUNX1 upregulates the expression of type 1 insulin-like growth factor receptor (IGF1R), thereby inhibiting T-ALL cell apoptosis and promoting proliferation. The gene discussed is IGF1R; the disease is acute lymphoblastic leukemia.